Abmart - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $97,794.63 -1.08%
Ethereum $3,409.92 +3.04%
BNB $658.28 +5.45%
Optimism $2.20 +1.98%
Arbitrum $0.85 +7.69%
Solana $255.93 +0.27%
Polygon $0.57 +21.45%
Cosmos $8.24 +12.32%
Avalanche $41.92 +5.52%

Bitcoin $97,794.63 -1.08%
Ethereum $3,409.92 +3.04%
BNB $658.28 +5.45%
Optimism $2.20 +1.98%
Arbitrum $0.85 +7.69%
Solana $255.93 +0.27%
Polygon $0.57 +21.45%
Cosmos $8.24 +12.32%
Avalanche $41.92 +5.52%

Abmart

company

Summary
Funding Rounds
Investors

About

Abmart specializes in antibody customization and antibody-related services.

101 - 250

Highlights

Total Funding Amount

Details

Last Funding Type: Series B
Last Funding Money Raised: ¥20M
Industries: Biotechnology,Medical,Pharmaceutical
Founded date: Jan 22, 2007
Number Of Employee: 101 - 250
Operating Status: Active

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

¥20M

Abmart has raised a total of ¥20M in funding over 2 rounds. Their latest funding was raised on Jun 12, 2018 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jun 12, 2018	Series B	¥20M	2	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

—

2

Abmart is funded by 2 investors. Puming Dianli Xitong Gongcheng and Unity Asset Management are the most recent investors.

Investor Name	Lead Investor	Funding Round
Puming Dianli Xitong Gongcheng	—	Series B
Unity Asset Management	—	Series B